Suzanne Ildstad

Insider Reports History

Entity
Individual
Location
C/O Talaris Therapeutics, Inc., 93 Worcester Street, Suite 120, Wellesley, MA
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Suzanne Ildstad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. Director Common Stock 3.77M $64.1M $16.99 Jun 14, 2023 Direct
Talaris Therapeutics, Inc. Director Common Stock 654K $11.1M $16.99 Jun 12, 2023 Indirect
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 20.5K Jun 13, 2023 Direct

Insider Reports Filed by Suzanne Ildstad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TALS Talaris Therapeutics, Inc. Jun 12, 2023 4 -$112K 4 Jun 14, 2023 Director
TALS Talaris Therapeutics, Inc. Jun 7, 2023 3 -$343K 4 Jun 9, 2023 Director
TALS Talaris Therapeutics, Inc. Jun 5, 2023 2 -$84.4K 4 Jun 7, 2023 Director
TALS Talaris Therapeutics, Inc. Jun 1, 2023 2 -$79.8K 4 Jun 5, 2023 Director
TALS Talaris Therapeutics, Inc. Apr 21, 2023 1 -$35.2K 4 Apr 25, 2023 Director
TALS Talaris Therapeutics, Inc. Apr 19, 2023 2 -$156K 4 Apr 21, 2023 Director
TALS Talaris Therapeutics, Inc. Apr 17, 2023 2 -$319K 4 Apr 19, 2023 Director
TALS Talaris Therapeutics, Inc. Mar 17, 2023 1 -$21.5K 4/A Apr 7, 2023 Director
TALS Talaris Therapeutics, Inc. Mar 3, 2023 1 -$14K 4/A Apr 7, 2023 Director
TALS Talaris Therapeutics, Inc. Mar 1, 2023 1 -$60 4/A Apr 7, 2023 Director
TALS Talaris Therapeutics, Inc. Feb 21, 2023 1 -$7.19K 4/A Apr 7, 2023 Director
TALS Talaris Therapeutics, Inc. Feb 16, 2023 2 -$13.4K 4/A Apr 7, 2023 Director
TALS Talaris Therapeutics, Inc. Aug 22, 2022 1 -$1.47M 4 Aug 23, 2022 Chief Scientific Officer
TALS Talaris Therapeutics, Inc. Feb 1, 2022 3 $0 4 Feb 2, 2022 Chief Scientific Officer